Literature DB >> 17382909

Kinetic analysis of reactivation and aging of human acetylcholinesterase inhibited by different phosphoramidates.

Franz Worek1, Nadine Aurbek, Marianne Koller, Christian Becker, Peter Eyer, Horst Thiermann.   

Abstract

The high number of fatalities due to poisoning by organophosphorus compound-based (OP) pesticides and the availability of highly toxic OP-type chemical warfare agents (nerve agents) emphasize the necessity for an effective medical treatment. Acute OP toxicity is mainly caused by inhibition of acetylcholinesterase (AChE, EC 3.1.1.7). Reactivators (oximes) of inhibited AChE are a mainstay of treatment. However, human AChE inhibited by certain OP, e.g. the phosphoramidates tabun and fenamiphos, is rather resistant towards reactivation by oximes while AChE inhibited by others, e.g. the phosphoramidate methamidophos is easily reactivated by oximes. To get more insight into a potential structure-activity relationship human AChE was inhibited by 16 different tabun analogues and the time-dependent reactivation by 1mM obidoxime, TMB-4, MMB-4, HI 6 or HLö 7, the reactivation kinetics of obidoxime and the kinetics of aging and spontaneous reactivation were investigated. A clear structure-activity relationship of aging, spontaneous and oxime-induced reactivation kinetics could be determined with AChE inhibited by N-monoalkyl tabun analogues depending on the chain length of the N-alkyl residue. N,N-dialkyl analogues bearing ethyl and n-propyl residues were completely resistant towards reactivation while N,N-di-i-propyl tabun was highly susceptible towards reactivation by oximes. AChE inhibited by phosphonoamidate analogues of tabun, bearing a N,N-dimethyl and N,N-diethyl group, could be reactivated and had comparable reactivation kinetics with obidoxime. These results in conjunction with previous data with organophosphates and organophosphonates emphasizes the necessity for kinetic studies as basis for future work on structural analysis with human AChE and for the development of effective broad-spectrum oximes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17382909     DOI: 10.1016/j.bcp.2007.02.008

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  11 in total

1.  Direct quantitation of methyl phosphonate adducts to human serum butyrylcholinesterase by immunomagnetic-UHPLC-MS/MS.

Authors:  Melissa D Carter; Brian S Crow; Brooke G Pantazides; Caroline M Watson; Jerry D Thomas; Thomas A Blake; Rudolph C Johnson
Journal:  Anal Chem       Date:  2013-11-08       Impact factor: 6.986

Review 2.  Efforts toward treatments against aging of organophosphorus-inhibited acetylcholinesterase.

Authors:  Qinggeng Zhuang; Amneh Young; Christopher S Callam; Craig A McElroy; Özlem Dogan Ekici; Ryan J Yoder; Christopher M Hadad
Journal:  Ann N Y Acad Sci       Date:  2016-06-21       Impact factor: 5.691

3.  Differential binding of bispyridinium oxime drugs with acetylcholinesterase.

Authors:  Manoj K Kesharwani; Bishwajit Ganguly; Amit Das; Tusar Bandyopadhyay
Journal:  Acta Pharmacol Sin       Date:  2010-02-08       Impact factor: 6.150

4.  Simultaneous measurement of tabun, sarin, soman, cyclosarin, VR, VX, and VM adducts to tyrosine in blood products by isotope dilution UHPLC-MS/MS.

Authors:  Brian S Crow; Brooke G Pantazides; Jennifer Quiñones-González; Joshua W Garton; Melissa D Carter; Jonas W Perez; Caroline M Watson; Dennis J Tomcik; Michael D Crenshaw; Bobby N Brewer; James R Riches; Sarah J Stubbs; Robert W Read; Ronald A Evans; Jerry D Thomas; Thomas A Blake; Rudolph C Johnson
Journal:  Anal Chem       Date:  2014-10-06       Impact factor: 6.986

5.  Energetics of Ortho-7 (oxime drug) translocation through the active-site gorge of tabun conjugated acetylcholinesterase.

Authors:  Vivek Sinha; Bishwajit Ganguly; Tusar Bandyopadhyay
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

6.  Acetylcholinesterase inhibitors: pharmacology and toxicology.

Authors:  Mirjana B Colović; Danijela Z Krstić; Tamara D Lazarević-Pašti; Aleksandra M Bondžić; Vesna M Vasić
Journal:  Curr Neuropharmacol       Date:  2013-05       Impact factor: 7.363

7.  Simultaneous Inhibitory Effects of All-Trans Astaxanthin on Acetylcholinesterase and Oxidative Stress.

Authors:  Xin Wang; Tao Zhang; Xiaochen Chen; Yating Xu; Zhipeng Li; Yuanfan Yang; Xiping Du; Zedong Jiang; Hui Ni
Journal:  Mar Drugs       Date:  2022-03-31       Impact factor: 6.085

8.  In silico studies in probing the role of kinetic and structural effects of different drugs for the reactivation of tabun-inhibited AChE.

Authors:  Rabindranath Lo; Nellore Bhanu Chandar; Manoj K Kesharwani; Aastha Jain; Bishwajit Ganguly
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

Review 9.  Organophosphorus compounds and oximes: a critical review.

Authors:  Franz Worek; Horst Thiermann; Timo Wille
Journal:  Arch Toxicol       Date:  2020-06-06       Impact factor: 5.153

10.  In Vitro Interaction of Organophosphono- and Organophosphorothioates with Human Acetylcholinesterase.

Authors:  Franz Worek; Horst Thiermann; Marianne Koller; Timo Wille
Journal:  Molecules       Date:  2020-07-02       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.